Tarsus Pharmaceuticals, Inc. — Form 4
Filed September 3, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
Chief Medical Officer Lin Elizabeth Yeu (TARS) sold 12K shares (~$898K) on the open market (71% of holdings). Large sale — ~71% of holdings.
Why this rating
Large sale — ~71% of holdings.
See more from September 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.